Tag - SOPH

Developments

SOPHiA GENETICS expands oncology portfolio with new RAM application

SOPHiA GENETICS (NASDAQ:SOPH) has announced its new residual acute myeloid (RAM) application, SOPHiA DDM RAM Solution, supporting measurable residual disease (MRD) testing to help monitor cancer and outpace relapse. The...

June 24, 2024

Markets

BTIG starts Sophia Genetics at buy; PT $6

BTIG initiated coverage of Sophia Genetics (NASDAQ:SOPH) with a “buy” rating and $6 price target. The stock price closed at $2.06 on Dec. 30. Sophia is a rapidly growing, global healthcare technology company that sells...

January 3, 2023

Tag - SOPH

SOPHiA GENETICS expands oncology portfolio with new RAM application

BTIG starts Sophia Genetics at buy; PT $6

General

More